NovoCure (NVCR) EBT (QoQ) (2014 - 2026)
Powered by 
Analysis
NovoCure (NVCR) EBT (QoQ) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 178.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.32 Bn | 119.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.42 Bn | 109.60 Bn | 6.34 Bn |
| 4 | Stryker | 105.22 Bn | 101.74 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.57 Bn | 66.03 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn |
| 10 | NovoCure | 1.90 Bn | 1.46 Bn | 142.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.02% |
| Mar 31, 2026 | -69.11% |
| Dec 31, 2025 | -36.41% |
| Sep 30, 2025 | 14.17% |
| Jun 30, 2025 | -15.46% |
| Mar 31, 2025 | 45.12% |
| Dec 31, 2024 | -155.76% |
| Sep 30, 2024 | 5.03% |
| Jun 30, 2024 | 28.17% |
| Mar 31, 2024 | 17.89% |
| Dec 31, 2023 | 20.09% |
| Sep 30, 2023 | 10.54% |
| Jun 30, 2023 | -5.53% |
| Mar 31, 2023 | -56.89% |
| Dec 31, 2022 | -39.04% |
| Sep 30, 2022 | -0.26% |
| Jun 30, 2022 | -828.67% |
| Mar 31, 2022 | 90.17% |
| Dec 31, 2021 | -142.79% |
| Sep 30, 2021 | 20.42% |